Sec. 5. A drug or device that, in accordance with the practice of the trade, is to be processed, labeled, or repacked in substantial quantities at an establishment other than the establishment where the drug or device was originally processed or packed, is exempt from the labeling and packaging requirements of IC 16-42-1 through IC 16-42-4 while the drug or device is in transit in intrastate commerce from one (1) establishment to the other if the transit is made in good faith for completion purposes only. However, the drug or device is otherwise subject to the applicable provisions of IC 16-42-1 through IC 16-42-4.
[Pre-1993 Recodification Citation: 16-1-30-14.]
As added by P.L.2-1993, SEC.25.
Structure Indiana Code
Article 42. Regulation of Food, Drugs, and Cosmetics
Chapter 3. Uniform Food, Drug, and Cosmetic Act: Adulteration and Misbranding of Drugs or Devices
16-42-3-1. Antibiotic Drug Defined
16-42-3-2. Established Name Defined
16-42-3-2.5. Duties of State Veterinarian and State Board of Animal Health
16-42-3-3. Adulterated Drug or Device
16-42-3-4. Misbranded Drug or Device
16-42-3-5. Exemption of Drugs or Devices in Transit for Further Processing, Labeling, or Repackaging
16-42-3-6. Drugs Dispensed on Prescription
16-42-3-7. New Drugs; Federal Qualification; Testing; Application to Introduce Drug
16-42-3-8. New Drugs; Time for Application to Take Effect
16-42-3-9. New Drugs; Exemption